ONC Q1 2020 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q1 2020 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$52M-33.1% YoY

Gross Profit

$38M72.8% margin

Operating Income

-$374M-717.9% margin

Net Income

-$364M-698.7% margin

EPS (Diluted)

$-4.68

QoQ Revenue Growth

-8.5%

Cash Flow

Operating Cash Flow

-$342M

Free Cash Flow

-$406M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$4.1B

Total Liabilities

$1.2B

Stockholders' Equity

$2.8B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$78M	-33.1%
Gross Profit	$38M	-$116M	+132.7%
Operating Income	-$374M	-$174M	-115.1%
Net Income	-$364M	-$168M	-117.0%